Search
Kura Oncology Inc
KURAAdd to Watchlist
7.270USD
+0.470+6.91%
Close 11-05 16:00（ET）
646.74MMarket Cap
LossP/E TTM
Today
+6.91%
5 Days
-31.16%
1 Month
-31.54%
6 Months
-21.74%
Year to Date
-30.03%
1 Year
-26.86%
Key Figures
6.910Open
7.700High
294.12KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.33%Turnover Ratio
6.800Prev. Close
6.755Low
2.08MTurnover
LossP/E Static
13.38P/B
0.00%Div Yield TTM
-42.19%ROA
13.90052wk High
0.09Volume Ratio
-173.98MNet Profit
88.96MShares
-3.3490EPS TTM
0.34Beta
-124.74%ROE
6.75552wk Low
13.90%Amplitude
98.71%Gross Margin
646.74MMarket Cap
0.47Reward/Risk
3.95%Risk Rate
Kura Oncology Inc's Score
-0.18vs previous score
Forecast8.38
Financial Health7.02
Technical5.16
Valuation Dimensions7.01
Institutional Confidence10.00
Risk Assessment5.15
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Kura Oncology Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Kura Oncology Inc Latest Earnings Call Transcripts
Kura Oncology (KURA) Q2 2026 Earnings Call: KOMZIFTI Sales Reach $9.1M
Kura Oncology’s Q2 2026 earnings call covered $9.1 million in KOMZIFTI sales, 115 new patient starts, pipeline updates and funding into 2028.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
2026-11-10
Reporting Period
2026Q2
Earnings / Forecast
-0.77/-0.88
Revenue / Forecast
20.87M/21.42M
Kura Oncology Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolKURA
Number of employees192
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BVF Partners L.P. | 9.71% |
| Suvretta Capital Management, LLC | 9.66% |
| BlackRock Institutional Trust Company, N.A. | 7.93% |
| Armistice Capital LLC | 5.56% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 37.46% |
| Investment Advisor | 28.87% |
| Investment Advisor/Hedge Fund | 24.85% |
| Research Firm | 4.92% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Kura Oncology Inc (KURA)?
The current price of Kura Oncology Inc (KURA) is 6.80.
What is the symbol of Kura Oncology Inc?
The ticker symbol of Kura Oncology Inc is KURA.
What is the 52-week high of Kura Oncology Inc?
The 52-week high of Kura Oncology Inc is 13.90.
What is the 52-week low of Kura Oncology Inc?
The 52-week low of Kura Oncology Inc is 6.76.
What is the market capitalization of Kura Oncology Inc?
The market capitalization of Kura Oncology Inc is 604.93M.
Is Kura Oncology Inc (KURA) currently rated as Buy, Hold, or Sell?
According to analysts, Kura Oncology Inc (KURA) has an overall rating of Buy, with a price target of 31.85.
What is the Earnings Per Share (EPS TTM) of Kura Oncology Inc (KURA)?
The Earnings Per Share (EPS TTM) of Kura Oncology Inc (KURA) is -3.35.